Skip to main content
Premium Trial:

Request an Annual Quote

BioMerieux Will Use Proteome Sciences Biomarkers to Develop Stroke Dx

NEW YORK, May 23 (GenomeWeb News) - Proteome Sciences today said it has penned a license agreement with bioMerieux to use its biomarkers in blood to detect, diagnose, and monitor stroke. 


Under the terms of the agreement, bioMerieux will test Proteome Sciences' biomarkers for a stroke diagnostic panel across a patient population in Continental Europe.


The biomarkers were discovered and validated using a combination of different proteomic approaches, all of which are available for external use through the proprietary ProteoSHOP platform.


Financial terms were not disclosed.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.